Loading chat...
WI AB68
Bill
Status
Introduced
2/24/2025
Primary Sponsor
Barbara Dittrich
Click for details
AI Summary
-
Extends the requirement for practitioners to review a patient's prescription drug monitoring program (PDMP) records before issuing a prescription from April 1, 2025 to April 1, 2030
-
Extends the Controlled Substances Board's mandate to conduct quarterly reviews comparing actual PDMP outcomes to projected outcomes from October 30, 2025 to October 30, 2030
-
Extends the reporting requirement for the board's PDMP review results from October 30, 2025 to October 30, 2030
-
Amends three sections of Wisconsin statute 961.385 related to prescription drug monitoring
Legislative Description
The prescription drug monitoring program. (FE)
Last Action
Laid on the table
3/20/2025
Committee Referrals
Rules3/13/2025
Health, Aging and Long-Term Care2/24/2025
Full Bill Text
No bill text available